Prospective Analysis of Value of Contrast-enhanced Sonography During Biopsies of Focal Liver Masses

Stopped early · Phase 4 · Has a placebo group

Conditions studied: Liver Biopsy

In brief

The investigators plan to compare complication and success rates between two methods of ultrasound guidance for biopsy of liver lesions, contrast-enhanced and the current protocol without contrast.

Key facts

Study ID

NCT03040323

Run by

Indiana University

People needed

83

Starts

2016-12-22

Expected to finish

2018-07-06

Last updated by the study team

2019-08-08

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Males and females
• Age 18 years or greater
• Scheduled to undergo liver biopsy with ultrasound guidance at a performance site

You may not qualify if…

• Liver biopsy is not intended to obtain tissue from a specific lesion
• Known or suspected cardiac shunt
• History of hypersensitivity to any active or inactive ingredients in Lumason

Where it is running

• Indiana University Health — Indianapolis, Indiana, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.